192
Views
3
CrossRef citations to date
0
Altmetric
Research Article

A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK

, MSc, , BSc Econ B Phil, , MSc DipPsych PhD, , MD FRCP FRCPsych & , PhD
Pages 29-40 | Accepted 08 Jun 2004, Published online: 02 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melissa H. Roberts, Mikiko Y. Takeda, Shannon Kindilien, Yazan K. Barqawi & Matthew E. Borrego. (2018) Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy. Expert Review of Pharmacoeconomics & Outcomes Research 18:5, pages 487-503.
Read now

Articles from other publishers (2)

Ben F.M. Wijnen, Ghislaine A.P.G. van Mastrigt, Silvia M.A.A. Evers, Olga Gershuni, Danielle A.J.E. Lambrechts, Marian H.J.M. Majoie, Debby Postulart, Bert A.P. Aldenkamp & Reina J.A. de Kinderen. (2017) A systematic review of economic evaluations of treatments for patients with epilepsy. Epilepsia 58:5, pages 706-726.
Crossref
Kristian Bolin & Lars Forsgren. (2012) The Cost Effectiveness of Newer Epilepsy Treatments. PharmacoEconomics 30:10, pages 903-923.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.